Factors impacting the delivery of therapeutic levels of pyrone-based HIV protease inhibitors.

Pharmaceutical biotechnology

Volumn 11, Issue , 1998, Pages 211-232

  Padbury, G E ^a   Zipp, G L ^a   Schwende, F J ^a   Zhao, Z ^a   Koeplinger, K A ^a   Chong, K T ^a   Raub, T J ^a   Thaisrivongs, S ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ANIMAL; DRUG DELIVERY SYSTEM; HUMAN; METABOLIC CLEARANCE RATE; PROTEIN BINDING; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG DELIVERY SYSTEMS; HIV PROTEASE INHIBITORS; HUMANS; METABOLIC CLEARANCE RATE; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031615876     PISSN: 10780467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)